CAPS — Capstone Therapeutics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $9.76m
- $12.13m
Annual cashflow statement for Capstone Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.77 | -1.61 | -1.75 | -0.38 | -2.71 |
Amortisation | |||||
Non-Cash Items | 0.174 | 0.035 | 0.068 | 0.253 | 0.262 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.287 | 0.136 | -0.079 | 0.036 | 0.734 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -2.15 | -1.26 | -1.56 | 0.066 | -1.68 |
Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Items | — | — | -0.015 | 0 | 0.046 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1 | 0.946 | 2.14 | 0 | 0.396 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.15 | -0.313 | 0.577 | 0.066 | -1.28 |